Biologic Alchemy: Transforming OMFS with Platelet-Derived Regenerative Therapies

Abstract

Autologous platelet concentrates specifically Platelet-Rich Plasma (PRP), Platelet-Rich Fibrin (PRF), and Growth Factor Concentrate (GFC) represent a
paradigm shift in regenerative strategies within Oral and Maxillofacial Surgery (OMFS). These biologically active formulations are derived from the patient’s own blood and are rich in a spectrum of growth factors, cytokines, and cellular mediators that orchestrate tissue repair and regeneration. By delivering a concentrated payload of bioactive molecules directly to surgical sites, they stimulate angiogenesis, modulate inflammation, and accelerate the proliferation and differentiation of progenitor cells. This targeted enhancement of the healing cascade makes platelet-derived therapies particularly valuable in clinical scenarios where tissue regeneration is suboptimal such as in compromised bone beds, irradiated tissues, or complex reconstructive procedures. Their versatility spans a wide array of OMFS applications, including alveolar ridge preservation, sinus augmentation, implantology, and the management of
osteonecrosis, offering clinicians a biologically intelligent adjunct to conventional surgical techniques.